Illumina, Inc.
ILMN Healthcare Diagnostics & Research
Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024.
- Revenue
- +4.15%
- EPS
- +49.0%
- Free cash flow
- +49.8%
- Total debt
- +80.0%
Quarter to September 2026, against a year earlier
Follow ILMN
Alert me
Illumina, Inc. (ILMN) EV/FCF
As of 5 November 2026, Illumina, Inc. (ILMN) trades at a EV/FCF of 31.3×. Over the past ten years it has ranged from −462× (March 2023) to 868× (August 2022); the current reading is higher than 21% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 22.6× | (27.48%) |
| FY2024 | 31.1× | (60.73%) |
| FY2023 | 79.3× | — |
| FY2022 | −407× | — |
| FY2021 | 176× | 201.52% |
| FY2020 | 58.2× | 5.72% |
| FY2019 | 55.1× | 9.81% |
| FY2018 | 50.2× | (11.17%) |
| FY2017 | 56.5× | 55.56% |
| FY2016 | 36.3× | (17.72%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 40.6× | 35.79% |
| Jun 2026 | 29.9× | 45.54% |
| Mar 2026 | 20.5× | (9.07%) |
| Dec 2025 | 22.6× | 50.89% |
| 43 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| GH Guardant Health, Inc. compare | −84.7× |
| DGX Quest Diagnostics Incorporated compare | 23.8× |
| IQV IQVIA Holdings Inc. compare | 27.5× |
| LH Labcorp Holdings Inc. compare | 29.8× |
| ILMN Illumina, Inc. | 31.3× |
| A Agilent Technologies, Inc. compare | 39.7× |
| IDXX IDEXX Laboratories, Inc. compare | 40.7× |
| MTD Mettler-Toledo International, Inc. compare | 41.4× |
| WAT Waters Corporation compare | 190× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on ILMN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement